TICKERNERD
Menu
AGLAGLHealthcare · Medical Care Facilities

AGL Stock Forecast: Agilon Health, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$97
+4.26% on the day

The 16 Wall Street analysts covering Agilon Health, Inc. hold a median 12-month price target of $115 — +18.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 63 of 100 as at 22 Aug 2026 — in the upper half.

Market cap
$1.6B
Ticker Nerd rank
63 / 100
Median analyst target
$115
Analysts covering
16
Total return, dividends reinvested
1W
−0.2%
1M
−23.1%
YTD
+461.3%
1Y
+214.4%
From 52W high
−25.5%
From 52W low
+1122.3%
$8
$130
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AGL stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Agilon Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
63 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
87
Growth
85
Revisions
76
Issuance
68
Momentum
65
Size
39
Value
37
Quality
16
Volatility
5

Accruals (87): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (5): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AGL stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AGL, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$50$100$150Oct 25Jan 26Apr 26Jul 26AGLHigh $146Median $115Low $85

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says16 analysts
4 Buy11 Hold1 Sell
Low $85Median $115High $146

The green dot is the last close — the median target sits +18.9% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 8 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
11 Aug 2026CitigroupUpgradeNeutral$105 → $115
11 Aug 2026Wells FargoMaintainsOverweight$141 → $146
6 Aug 2026BarclaysMaintainsEqual-Weight$81 → $111
6 Aug 2026BenchmarkMaintainsBuy$95 → $140
6 Aug 2026Evercore ISI GroupMaintainsIn-Line$120 → $125
6 Aug 2026Truist SecuritiesMaintainsHold$67 → $112
23 July 2026CitigroupDowngradeSell—
23 July 2026CitigroupDowngradeSell$80 → $105
13 July 2026Wells FargoMaintainsOverweight$72 → $141
13 July 2026Wells FargoMaintainsOverweight—
26 May 2026BarclaysUpgradeEqual-Weight—
21 May 2026BenchmarkMaintainsBuy—
15 May 2026CitigroupMaintainsNeutral—
11 May 2026TD CowenMaintainsHold—
8 May 2026Wells FargoMaintainsOverweight—
7 May 2026BairdMaintainsNeutral—
7 May 2026Deutsche BankUpgradeBuy—
7 May 2026Evercore ISI GroupMaintainsIn-Line—
7 May 2026JefferiesUpgradeBuy—
4 May 2026JP MorganDowngradeUnderweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AGL appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

AGL analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
3
Analysts cutting
1
Fundamentals

Agilon Health, Inc. (AGL) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−4.1×

Cheaper than 88% of US stocks

Price / sales
0.3×

Cheaper than 91% of US stocks

Price / book
7.1×

Cheaper than 16% of US stocks

EV / EBITDA
−6.1×

Cheaper than 79% of US stocks

Growth & margins
Revenue growth (YoY)
7.2%

Higher than 45% of US stocks

Earnings growth (YoY)
7.2%

Higher than 44% of US stocks

Gross margin
7.2%

Higher than 7% of US stocks

Operating margin
1.3%

Higher than 47% of US stocks

Net margin
−3.9%

Higher than 25% of US stocks

Returns & dividend
Return on equity
−78.9%

Higher than 16% of US stocks

Return on assets
−9.6%

Higher than 27% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

AGL vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
AGLAgilon Health, Inc.$1.6B
63
HCSGHealthcare Services Group, Inc.$1.6B
97
ARDTArdent Health, Inc.$1.6B
56
INNVInnovAge Holding Corp.$1.5B
96
SNDASonida Senior Living, Inc.$1.9B
27
SGRYSurgery Partners, Inc.$1.9B
47
PNTGThe Pennant Group, Inc.$1.3B
72

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Agilon Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AGL news & analysis

agilon health to Participate in Upcoming Conferences

Business Wire · 20 Aug 2026neutral

agilon health announced that its management team will participate in fireside chats at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, and and the ick... let me correct: at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, and the 20226 Jefferies Healthcare Services and Technology Conference on September 14, 2026. A live webcast will be available on the company's investor relations page.

Why it matters — The conference appearances give investors an opportunity to hear directly from agilon's management about the company's strategy and outlook.

Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year?

Zacks Investment Research · 12 Aug 2026neutral

Zacks Investment Research published an article comparing the year-to-date performance of Agilon Health (AGL) and Biodesix, Inc. (BDSX) against their medical sector. The piece examines how the two stocks have performed relative to the broader sector this year without providing specific figures.

Why it matters — AGL watchers can gauge how the company's recent stock performance compares with a sector peer and the wider medical market.

agilon health: The Q2 Inflection Is Real

Seeking Alpha · 7 Aug 2026positive

agilon Health reported a strong Q2 2026 with revenue of $1.49B, a $250M year-over-year medical margin swing, and raised its full-year guidance across all key metrics. The operational turnaround is supported by improved cost trends, enhanced data pipelines, and clinical pathway execution, with balance sheet strength from over $220M in net cash.

Why it matters — For AGL watchers, this report indicates a confirmed operational inflection, evidenced by reduced inpatient first-diagnosis rates and stronger profitability backed by disciplined membership management.

agilon health, inc. (AGL) Q2 2026 Earnings Call Transcript

Seeking Alpha · 6 Aug 2026neutral

agilon health held its Q2 2026 earnings conference call, during which management discussed the company's financial results and operational performance for the quarter.

Why it matters — The earnings call provides AGL watchers with direct insight into the company's latest financial health, strategic priorities, and management's perspective on current operations.

Agilon Health Q2 Earnings Call Highlights

MarketBeat · 6 Aug 2026positive

Agilon Health reported second-quarter results that exceeded its guidance for medical margin and adjusted EBITDA, citing stronger risk-adjustment revenue, favorable medical-cost development, and progress in clinical and quality initiatives. The company also raised its full-year 2026 outlook.

Why it matters — The company beat guidance on key financial metrics and raised its full-year outlook, signaling stronger operational performance for the remainder of the year.

FAQ

Frequently asked questions about AGL stock

What is the AGL stock price forecast for 2026-2027?

The 16 Wall Street analysts covering Agilon Health, Inc. have a median 12-month price target of $115, with estimates ranging from $85 to $146. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AGL stock a buy right now?

Of the 16 analysts covering Agilon Health, Inc., 4 rate it a Buy, 11 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Agilon Health, Inc. 63 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AGL?

As at 22 Aug 2026, Agilon Health, Inc. ranks 63 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (87 of 100).

Will AGL stock go up?

No one can know that. What the data says: the median 12-month target from 16 analysts implies +18.9% from the last close, and Ticker Nerd's factor model ranks Agilon Health, Inc. 63 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AGL stock forecast for 2030?

No analyst covering Agilon Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AGL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $85 to $146 over the next 12 months.

How has AGL stock performed over the past year?

Agilon Health, Inc. returned +214.4% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Agilon Health, Inc. do?

Agilon Health Inc. is a healthcare services company that specializes in value-based care for seniors in the United States.

What is the latest news on AGL?

The most recent item we track (Business Wire, 20 Aug 2026): "agilon health to Participate in Upcoming Conferences". agilon health announced that its management team will participate in fireside chats at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, and and the ick... let me correct: at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, and the 20226 Jefferies Healthcare Services and Technology Conference on September 14, 2026. A live webcast will be available on the company's investor relations page.

Company

About Agilon Health, Inc.

Agilon Health Inc. is a healthcare services company that specializes in value-based care for seniors in the United States. The company partners with community-based primary care physician groups and health systems, providing a comprehensive operating platform that supports managing the total cost and quality of care for Medicare-focused populations. Agilon Health supplies technology, data analytics, payer contracting capabilities, care coordination programs, and clinical and operational support that enable physicians to assume and manage financial risk while maintaining their independence and focusing on outcomes for older adults. Its Total Care Model connects payers, physicians, and patients through integrated clinical and financial management, emphasizing coordinated, preventive, and population-health-oriented care. Agilon Health operates across multiple local markets in the U.S., building long-term partnerships rather than a direct-to-consumer presence, and plays a significant role in the Medicare Advantage and broader senior-care ecosystem by helping provider organizations transition from fee-for-service to value-based payment structures. Founded in 2016 and headquartered in Westerville, Ohio, the company is positioned at the intersection of healthcare services and health technology for senior populations.

CEO Mr. Timothy Patrick O'Rourke · 856 employees · United States · https://www.agilonhealth.com